NCT02836600View on ClinicalTrials.gov

A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 9, 2016

Primary Completion Date

July 5, 2019

Study Completion Date

May 30, 2023

Conditions
Advanced Solid Tumor
Interventions
DRUG

LY3039478

Administered orally

Trial Locations (1)

277 8577

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kashiwa

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02836600 - A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter